Abstract: A method and system for evaluating physiological properties of a segment of blood vessel is provided. The method includes: acquiring a first measurement and a second measurement respectively at the first point and the second point; obtaining a transfer function configured to produce an output given an input, using the first measurement and the second measurement as the input and the output respectively; and determining the physiological properties of the section of the blood vessel based on the transfer function. The transfer function can be a velocity transfer function based on the blood velocity waveforms, or can be a pressure transfer function based on the blood pressure waveforms. The method and system can be used to non-invasively diagnose PH, COPD, and PA impedance in a pulmonary artery, and to detect a stenosis in a coronary artery.
Type:
Application
Filed:
November 10, 2017
Publication date:
May 10, 2018
Applicants:
Auburn University, The UAB Research Foundation
Inventors:
Thomas S. DENNEY, JR., Himanshu GUPTA, Ankur GUPTA
Abstract: In some embodiments, a hand washing compliance system includes a primary soap dispenser adapted to be located near an entrance to a room, the primary soap dispenser comprising a motion sensor configured to detect passage of an individual through the room entrance, a soap dispensation sensor configured to detect dispensation of soap from the primary soap dispenser, and a communication device configured to enable communication with other soap dispensers, and a secondary soap dispenser adapted to be located inside of the room, the secondary soap dispenser comprising a soap dispensation sensor configured to detect dispensation of soap from the secondary soap dispenser, a communication device configured to enable communication with other soap dispensers, and a warning indicator configured to generate an alert that encourages individuals entering the room to wash their hands.
Abstract: A method of fabrication of laser gain material and utilization of such media includes the steps of introducing a transitional metal, preferably Cr2+ thin film of controllable thickness on the ZnS crystal facets after crystal growth by means of pulse laser deposition or plasma sputtering, thermal annealing of the crystals for effective thermal diffusion of the dopant into the crystal volume with a temperature and exposition time providing the highest concentration of the dopant in the volume without degrading laser performance due to scattering and concentration quenching, and formation of a microchip laser either by means of direct deposition of mirrors on flat and parallel polished facets of a thin Cr:ZnS wafer or by relying on the internal reflectance of such facets.
Abstract: The present invention provides methods, compounds, compositions and kits including mitochondrially-targeted electrophilic (MTE) compounds that are useful for treating cancer.
Abstract: Described herein are nitrated lipids and methods of making and using the nitrated lipids.
Type:
Grant
Filed:
November 21, 2016
Date of Patent:
January 16, 2018
Assignees:
The UAB Research Foundation, The State of Oregon Acting by and through the State Board of Higher Education on Behalf of the University of Oregon, University College Cardiff Consultants Limited, Morehouse School of Medicine, Inc.
Inventors:
Bruce A. Freeman, Francisco Schopfer, Valerie O'Donnell, Paul Baker, Yuqing E. Chen, Bruce Branchaud
Abstract: A self-restoring crash cushion including multiple diaphragms spaced along a length direction of the cushion, an elongated track adapted to be anchored to the ground that extends along the length direction under the cushion, the diaphragms being mounted to the track in a manner in which they can slide along the track when impacted by a moving vehicle or when the cushion is being restored, and means for dissipating energy of the moving vehicle.
Type:
Grant
Filed:
March 7, 2015
Date of Patent:
January 2, 2018
Assignee:
The UAB Research Foundation
Inventors:
Dean Sicking, David Littlefield, Kenneth Walls, Seth Cohen, Kevin Schrum
Abstract: The present invention relates, in general, to an immunogenic composition (e.g., a vaccine) and, in particular, to a polyvalent immunogenic composition, such as a polyvalent HIV vaccine, and to methods of using same. The invention further relates to methods that use a genetic algorithm to create sets of polyvalent antigens suitable for use, for example, in vaccination strategies.
Type:
Grant
Filed:
May 29, 2015
Date of Patent:
December 19, 2017
Assignees:
Duke University, Los Alamos National Security, LLC, Beth Israel Deconess Medical Center, The UAB Research Foundation
Inventors:
Bette T. Korber, William Fischer, Norman Letvin, Hua-Xin Liao, Barton F. Haynes, Beatrice H. Hahn
Abstract: The disclosure relates to nucleic acids mosaic clade M HIV-1 Env polypeptides and to compositions and vectors comprising same. The nucleic acids are suitable for use in inducing an immune response to HIV-1 in a human.
Type:
Grant
Filed:
April 17, 2015
Date of Patent:
November 21, 2017
Assignees:
Duke University, Los Alamos National Security, LLC, The UAB Research Foundation, Beth Israel Deaconess Medical Center
Inventors:
Bette T. Korber, William Fischer, Hua-Xin Liao, Barton F. Haynes, Norman Letvin, Beatrice H. Hahn
Abstract: In one embodiment, a hinged microfracture awl includes a handle, and a shaft that extends through and from the handle, the shaft being pivotally mounted to the handle with a hinge, wherein a distal end of the shaft includes a sharp tip adapted to pierce bone and a proximal end of the shaft includes an impact head adapted to be struck by a striking tool.
Type:
Grant
Filed:
May 21, 2015
Date of Patent:
November 7, 2017
Assignees:
THE UAB RESEARCH FOUNDATION, SOUTHERN RESEARCH INSTITUTE
Inventors:
Reed Estes, Patrick Schexnailder, Robert Hergenrother
Abstract: Various aspects related to the preparation of congeners of the aminoglycosides gentamicin such as the congener C2 and using this compound or derivatives thereof and pharmaceutically active salts to treat diseases that involve genetic mutations which introduce a missense or premature stop codon into a gene. Still other aspects include treating human or animal patients with the gentamicin congener C2 and derivatives and pharmaceutical salt thereof to overcome, or to at least mitigate, the symptoms of disease and disorders such as some forms of Becker's or Duchenne muscular dystrophy, Hurler's Syndrome and Cystic Fibrosis that have as their etiology the presence of a premature stop codon in a gene whose proper expression is necessary for good health.
Type:
Grant
Filed:
January 5, 2015
Date of Patent:
October 3, 2017
Assignees:
Indiana University Research and Technology Corporation, UAB Research Foundation
Inventors:
Bruce A. Molitoris, David M. Bedwell, Ruben M. Sandoval
Abstract: Disclosed is a new and emerging serotype of Streptococcus pneumoniae designated serotype 6C, and assays and monoclonal antibodies useful in identifying same. Also disclosed is a novel pneumococcal polysaccharide with the repeating unit {2) glucose 1 (1?3) glucose 2 (1?3) rhamnose (1?3) ribitol (5?phosphate}. This new serotype may be included in pneumococcal vaccines.
Type:
Grant
Filed:
May 9, 2013
Date of Patent:
October 3, 2017
Assignees:
The UAB Research Foundation, Fundacao Oswaldo Cruz, Instituto Adolfo Lutz
Inventors:
Moon H. Nahm, Jisheng Lin, Angela P. Brandao, Maria Cristina Brandileone
Abstract: Despite significant progress in the synthesis of nanocomposite materials, integration of several components with various functions remains a big challenge, which significantly limits control over nanocomposite properties. The disclosure provides a multifunctional micro particle based on incorporation of titania nanoparticles combined into a porous polylactic acid (PLA) matrix. PLA is used as a biodegradable and biocompatible polymer and titania nanoparticles represent photocatalytically active nanofillers capable of degradation of organic compounds under solar irradiation. Titania nanoparticles are integrated with PLA by using ‘mixed’ and ‘in situ grown’ approaches. The hybrid systems effectively absorbed and degraded organic impurities from water. The sorption capacity, dye degradability, and PLA disintegration were controlled by varying the concentration of incorporated titania.
Type:
Grant
Filed:
June 18, 2012
Date of Patent:
September 19, 2017
Assignee:
The UAB Research Foundation
Inventors:
Eugenia P. Kharlampieva, Benjamin Yancey
Abstract: Provided herein are methods and systems for image registration from multiple sources. A method for image registration includes rendering a common field of interest that reflects a presence of a plurality of elements, wherein at least one of the elements is a remote element located remotely from another of the elements and updating the common field of interest such that the presence of the at least one of the elements is registered relative to another of the elements.
Type:
Grant
Filed:
August 12, 2011
Date of Patent:
September 12, 2017
Assignees:
UAB RESEARCH FOUNDATION, HELP LIGHTNING, INC.
Inventors:
Marcus W. Dillavou, Phillip Corey Shum, Baron L. Guthrie, Mahesh B. Shenai, Drew Steven Deaton, Matthew Benton May
Abstract: The present method describes a new method for the measurement of dark adaptation. The dark adaptation status of subjects may then be used to identify those subjects who are at risk of developing and/or who are currently suffering from a variety of disease states having their clinical manifestations in impaired dark adaptation. The disease states include, but are not limited to, age related macular degeneration, vitamin A deficiency, Sorsby's Fundus Dystrophy, late autosomal dominant retinal degeneration, retinal impairment related to diabetes and diabetic retinopathy. An apparatus for administering the test method described is also provided.
Abstract: Provided herein are Mycobacterium smegmatis porin nanopores, systems that comprise these nanopores, and methods of using and making these nanopores. Such nanopores may be wild-type MspA porins, mutant MspA porins, wild-type MspA paralog porins, wild-type MspA homolog porins, mutant MspA paralog porins, mutant MspA homolog porins, or single-chain Msp porins. Also provided are bacterial strains capable of inducible Msp porin expression.
Type:
Application
Filed:
April 14, 2017
Publication date:
August 3, 2017
Applicants:
University of Washington, The UAB Research Foundation
Inventors:
Jens H. Gundlach, Michael Niederweis, Thomas Z. Butler, Mikhail Pavlenok, Mark A. Troll, Suja Sukumaran
Abstract: An antibody of the invention interacts with human DR5 to produce agonistic or antagonistic effects downstream of the receptor including inhibition of cell proliferation and apoptosis. Nucleic acid sequences and amino acid sequences of anti-DR5 antibodies have been elucidated and vectors and cells containing and expressing these sequences have been generated. Methods and uses for the antibodies are detailed including treatment of apoptosis-related disease and treatment of dysregulated cell growth.
Type:
Grant
Filed:
March 12, 2014
Date of Patent:
July 11, 2017
Assignee:
The UAB Research Foundation
Inventors:
Tong Zhou, Kimihisa Ichikawa, Robert P. Kimberly, William J. Koopman
Abstract: It has been surprisingly discovered that administration of nitrite to subjects causes a reduction in blood pressure and an increase in blood flow to tissues. The effect is particularly beneficial, for example, to tissues in regions of low oxygen tension. This discovery provides useful treatments to regulate a subject's blood pressure and blood flow, for example, by the administration of nitrite salts. Provided herein are methods of administering a pharmaceutically-acceptable nitrite salt to a subject, for treating, preventing or ameliorating a condition selected from: (a) ischemia-reperfusion injury (e.g., hepatic or cardiac or brain ischemia-reperfusion injury); (b) pulmonary hypertension (e.g., neonatal pulmonary hypertension); or (c) cerebral artery vasospasm.
Type:
Grant
Filed:
January 5, 2015
Date of Patent:
July 11, 2017
Assignees:
The United States of America as represented by the Secretary of the Department of Health and Human Services, The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, Acting through the Louisiana State University Health Sciences Center, The UAB Research Foundation, Loma Linda University, Wake Forest University
Inventors:
Mark T. Gladwin, Alan N. Schechter, David J. Lefer, Rakesh P. Patel, Christian J. Hunter, Gordon G. Power, Daniel B. Kim-Shapiro, Ryszard Marek Pluta, Edward H. Oldfield, Richard O. Cannon, III
Abstract: A transport chair is provided that includes a base frame, a seat assembly pivotally mounted to the base, and a footrest assembly pivotally mounted to the base frame, the footrest assembly being associated with the seat assembly so as to pivot in unison with the seat assembly until the seat assembly is pivoted forward to an extent at which the footrest assembly contacts the floor or ground, at which point the footrest assembly does not pivot further upon further forward pivoting of the seat assembly. Further embodiments of the transport chair allow the seat assembly to recline, alone or in unison with a leg rest assembly, while the footrest remains in position.